154 related articles for article (PubMed ID: 20868557)
1. Literature analysis of radiotherapy for esophageal cancer in China.
Zhou ZG; Gao XS; Qiao XY; Zhang P
Chin J Cancer; 2010 Oct; 29(10):873-81. PubMed ID: 20868557
[TBL] [Abstract][Full Text] [Related]
2. [Phase II clinical trial of concurrent chemoradiotherapy (cisplatin plus 5-fluorouracil) for esophageal cancer].
Lin Q; Gao XS; Qiao XY; Chen K; Wang YD; Zhou ZG
Ai Zheng; 2008 Oct; 27(10):1077-81. PubMed ID: 18851788
[TBL] [Abstract][Full Text] [Related]
3. Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study.
Zhai Y; Hui Z; Wang J; Zou S; Liang J; Wang X; Lv J; Chen B; Zhu H; Wang L
Dis Esophagus; 2013 Jul; 26(5):503-9. PubMed ID: 22862289
[TBL] [Abstract][Full Text] [Related]
4. [The efficacy and safety of high dose versus standard dose radiotherapy in concurrent chemoradiotherapy for patients with esophageal squamous cell carcinoma].
Ren XJ; Wang L; Han C; Liu LL
Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):135-139. PubMed ID: 30862144
[No Abstract] [Full Text] [Related]
5. Clinical Study on Lobaplatin Combined with 5-Fu and Concurrent Radiotherapy in Treating Patients with Inoperable Esophageal Cancer.
Jia XJ; Huang JZ
Asian Pac J Cancer Prev; 2015; 16(15):6595-7. PubMed ID: 26434880
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of late course accelerated hyperfractionated radiotherapy combined with FP chemotherapy for esophageal carcinoma.
Liu CX; Li XY; Gao XS
Chin J Cancer; 2010 Oct; 29(10):889-99. PubMed ID: 20868559
[TBL] [Abstract][Full Text] [Related]
7. Moderately hypofractionated conformal radiation treatment of thoracic esophageal carcinoma.
Ma JB; Wei L; Chen EC; Qin G; Song YP; Chen XM; Hao CG
Asian Pac J Cancer Prev; 2012; 13(8):4163-7. PubMed ID: 23098423
[TBL] [Abstract][Full Text] [Related]
8. [Concurrent chemoradiation with paclitaxel and platinum for locally advanced esophageal cancer].
Zhang P; Xie CY; Wu SX
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):773-7. PubMed ID: 18396692
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical outcome of intensity-modulated radiation therapy for locally advanced esophageal squamous cell carcinoma.
Ge X; Yang X; Lu X; Wen W; Zhen F; Ye H; Zhu H; Cao Y; Zhang S; Cheng H; Ma J; Yang B; Dai S; Guo Q; Cai J; Sun X
Tumori; 2015; 101(2):168-73. PubMed ID: 25791535
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of safety profile of high-dose concurrent chemoradiotherapy for patients with oesophageal squamous cell carcinoma.
Ren X; Wang L; Han C; Ren L
Radiother Oncol; 2018 Nov; 129(2):293-299. PubMed ID: 30270099
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma: early results of a phase II study.
Yu WW; Zhu ZF; Fu XL; Zhao KL; Mao JF; Wu KL; Yang HJ; Fan M; Zhao S; Welsh J
Strahlenther Onkol; 2014 Oct; 190(11):979-86. PubMed ID: 24609941
[TBL] [Abstract][Full Text] [Related]
12. A retrospective study of external beam radiation, neutron brachytherapy, and concurrent chemotherapy for patients with localized advanced carcinoma of the esophagus.
Ma K; Wang Q; Li T; Liu H; Liu B; Jia X; Li S; Lang J; Zhang M
Radiat Oncol; 2014 Dec; 9():294. PubMed ID: 25515326
[TBL] [Abstract][Full Text] [Related]
13. Esophageal cancer treated with radiotherapy: impact of total treatment time and fractionation.
Nishimura Y; Ono K; Tsutsui K; Oya N; Okajima K; Hiraoka M; Abe M
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1099-105. PubMed ID: 7961017
[TBL] [Abstract][Full Text] [Related]
14. Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).
Zehentmayr F; Söhn M; Exeli AK; Wurstbauer K; Tröller A; Deutschmann H; Fastner G; Fussl C; Steininger P; Kranzinger M; Belka C; Studnicka M; Sedlmayer F
Radiat Oncol; 2015 May; 10():121. PubMed ID: 26018527
[TBL] [Abstract][Full Text] [Related]
15. Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study.
Zhao KL; Shi XH; Jiang GL; Yao WQ; Guo XM; Wu GD; Zhu LX
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1014-20. PubMed ID: 15990003
[TBL] [Abstract][Full Text] [Related]
16. Chemoradiotherapy and radiotherapy alone in patients with esophageal cancer aged 80 years or older based on the Comprehensive Registry of Esophageal Cancer in Japan.
Jingu K; Numasaki H; Toh Y; Nemoto K; Uno T; Doki Y; Matsubara H
Esophagus; 2020 Jul; 17(3):223-229. PubMed ID: 32088786
[TBL] [Abstract][Full Text] [Related]
17. [Curative Effect of Jiedu Shengji Recipe in Preventing and Treating Acute Radiation Esophagitis in Radiotherapy Induced Esophageal Carcinoma Patients].
Cui Z; Liu W; Zhou Y; Wang CG; Liu JJ; Li DJ; Jiang H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jul; 36(7):810-813. PubMed ID: 30634207
[TBL] [Abstract][Full Text] [Related]
18. Re-evaluating the optimal radiation dose for definitive chemoradiotherapy for esophageal squamous cell carcinoma.
He L; Allen PK; Potter A; Wang J; Chang JY; Gomez DR; Komaki R; Liao Z; Lin SH
J Thorac Oncol; 2014 Sep; 9(9):1398-405. PubMed ID: 25122435
[TBL] [Abstract][Full Text] [Related]
19. Comparison between continuous accelerated hyperfractionated and late-course accelerated hyperfractionated radiotherapy for esophageal carcinoma.
Wang Y; Shi XH; He SQ; Yao WQ; Wang Y; Guo XM; Wu GD; Zhu LX; Liu TF
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):131-6. PubMed ID: 12182982
[TBL] [Abstract][Full Text] [Related]
20. Concurrent chemo-radiotherapy with S-1 as an alternative therapy for elderly Chinese patients with non-metastatic esophageal squamous cancer: evidence based on a systematic review and meta-analysis.
Song GM; Tian X; Liu XL; Chen H; Zhou JG; Bian W; Chen WQ
Oncotarget; 2017 Jun; 8(23):37963-37973. PubMed ID: 28415814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
